Etiology, Diagnosis and Treatment of Lymphocutaneous Fistulas, Chylascites and Chylothorax as Infrequent but Serious Complications Following Surgical Procedures*[1]

References

• 1 Kwaan J H, Bernstein J M, Connolly J E. Management of lymph fistula in the groin after arterial reconstruction.  Arch Surg. 1979;  114 1416-1418
• 2 Pimpl W, Thalheimer J, Rieger R et al. Immunologic capacity and blood circulation of splenic autotransplants – experimental results in swine.  Langenbecks Arch Chir. 1986;  369 399-403
• 3 Kent K C, Bartek S, Kuntz K M et al. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: incidence, risk factors, and cost.  Surgery. 1996;  119 378-383
• 4 Giovannacci L, Eugster T, Stierli P et al. Does fibrin glue reduce complications after femoral artery surgery? A randomised trial.  Eur J Vasc Endovasc Surg. 2002;  24 196-201
• 5 Tyndall S H, Shepard A D, Wilczewski J M et al. Groin lymphatic complications after arterial reconstruction.  J Vasc Surg. 1994;  19 858-864
• 6 Schwartz M A, Schanzer H, Skladany M et al. A comparison of conservative therapy and early selective ligation in the treatment of lymphatic complications following vascular procedures.  Am J Surg. 1995;  170 206-208
• 7 Steele S R, Martin M J, Mullenix P S et al. Intraoperative use of isosulfan blue in the treatment of persistent lymphatic leaks.  Am J Surg. 2003;  186 9-12
• 8 Croft R J. Lymphatic fistula: a complication of arterial surgery.  Br Med J. 1978;  2 205
• 9 Neu B, Gauss G, Haase W et al. Radiotherapy of lymphatic fistula and lymphocele.  Strahlenther Onkol. 2000;  176 9-15
• 10 Dietl B, Pfister K, Aufschläger C et al. Die Strahlentherapie inguinaler Lymphfisteln nach gefäßchirurgischen Eingriffen.  Strahlenther Onkol. 2005;  181 396-400
• 11 Mayer R, Sminia P, McBride W H et al. Lymphatic fistulas: Obliteration by low-dose radiotherapy.  Strahlenther Onkol. 2005;  181 660-664
• 12 Hillerdal G. Chylothorax and pseudochylothorax.  Eur Respir J. 1997;  10 1157-1162
• 13 Cnotliwy M, Gutowski P, Petriczko W et al. Doxycycline treatment of groin lymphatic fistulae following arterial reconstruction procedures.  Eur J Vasc Endovasc Surg. 2001;  21 469-470
• 14 Hackert T, Werner J, Loos M et al. Successful doxycycline treatment of lymphatic fistulas: report of five cases and review of the literature.  Langenbecks Arch Surg. 2006;  391 435-438
• 15 Greer S E, Adelman M, Kasabian A et al. The use of subatmospheric pressure dressing therapy to close lymphocutaneous fistulas of the groin.  Br J Plast Surg. 2000;  53 484-487
• 16 Argenta L C, Morykwas M J. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience.  Ann Plast Surg. 1997;  38 563-576
• 17 Morykwas M J, Argenta L C, Shelton-Brown E I et al. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation.  Ann Plast Surg. 1997;  38 553-562
• 18 Carcoforo O, Solani G, Maestroni U et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.  J Am Coll Surg. 2003;  196 365-369
• 19 Coveney E C, O’Dwyer P J, Geraghty J G et al. Effect of closing dead space on seroma formation after mastectomy – a prospective randomized clinical trial.  Eur J Surg Oncol. 1993;  19 143-146
• 20 Schultz I, Barholm M, Grondal S. Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study.  Ann Surg Oncol. 1997;  4 293-297
• 21 Moore M, Burak W, Nelson E et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial.  J Am Coll Surg. 2001;  192 591-599
• 22 Mustonen P K, Härmä M A, Eskelinen M J. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial.  Scand J Surg. 2004;  93 209-212
• 23 Erisen L, Coskun H, Basut O. Objective and early diagnosis of chylous fistula in the postoperative period.  Otolaryngol Head Neck Surg. 2002;  126 172-175
• 24 Suver D W, Perkins J A, Manning S C. Somatostatin treatment of massive lymphorrhea following excision of a lymphatic malformation.  Int J Pediatr Otorhinolaryngol. 2004;  68 845-850
• 25 Cardenas A, Chopra S. Chylous ascites.  Am J Gastroenterol. 2002;  97 1896-1900
• 26 Browse N L, Wilson N M, Russo F et al. Aetiology and treatment of chylous ascites.  Br J Surg. 1992;  79 1145-1150
• 27 Jensen E H, Weiss C A. Management of chylous ascites after laparoscopic cholecystectomy using minimally invasive techniques: a case report and literature review.  Am Surg. 2006;  72 60-63
• 28 Halloul Z, Meyer F, Burger T et al. Chylous ascites, a rare complication of aortic surgery.  Vasa. 1995;  24 377-381
• 29 Leibovitch I, Mor Y, Golomb J et al. The diagnosis and management of postoperative chylous acites.  J Urol. 2002;  167 449-457
• 30 Kaas R, Rustman L D, Zoetmulder F A. Chylous ascites after oncological abdominal surgery: incidence and treatment.  Eur J Surg Oncol. 2001;  27 187-189
• 31 Chan K Y, Teoh C M, Sukumar N. Chylous ascites after anterior resection for rectal carcinoma: a rare but significant incident.  Asian J Surg. 2006;  29 46-48
• 32 Aalami O O, Allen D B, Organ C H. Chylous ascites: a collective review.  Surgery. 2000;  128 761-778
• 33 Pui M H, Yueh T C. Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax.  J Nucl Med. 1998;  39 1292-1296
• 34 Laterre P F, Dugernier T, Reynaert M S. Chylous ascites: diagnosis, causes and treatment.  Acta Gastroenterol Belg. 2000;  63 260-263
• 35 Combe J, Buniet J M, Douge C et al. Chylothorax and chylous ascites following surgery of an inflammatory aortic aneurysm. Case report with review of the literature.  J Mal Vasc. 1992;  17 151-156
• 36 Huang Q, Jiang Z W, Jiang J et al. Chylous ascites: treated with total parenteral nutrition and somatostatin.  World J Gastroenterol. 2004;  10 2588-2591
• 37 Jensen G L, Mascioli E A, Meyer L P et al. Dietary modification of chyle composition in chylothorax.  Gastroenterology. 1989;  97 761-765
• 38 Guillem P, Billeret V, Lecomte Houcke M et al. Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine.  Dis Esophagus. 1999;  12 155-156
• 39 Almakdisi T, Massoud S, Makdisi G. Lymphomas and chylous ascites: review of the literature.  Oncologist. 2005;  10 632-635
• 40 Jonas J, Kaissling G, Druschky K .F et al. The transsternal thymectomy. Indication of operation and perioperative management.  Zentralbl Chir. 2000;  125 671-677
• 41 Kick J, Schelzig H, Heinecke A et al. Resection of lung metastases – risk or chance?.  Zentralbl Chir. 2005;  130 534-538
• 42 Terzi A, Furlan G, Magannelli G et al. Chylothorax after pleuro-pulmonary surgery: a rare but unavoidable complication.  Thorac Cardiovasc Surg. 1994;  42 81-84
• 43 Shimizu J, Hayashi Y, Oda M et al. Treatment of postoperative chylothorax by pleurodesis with the streptococcal preparation OK-432.  Thorac Cardiovasc Surg. 1994;  42 233-236
• 44 Dougenis D, Walker W S, Cameron E W et al. Management of chylothorax complicating extensive esophageal resection.  Surg Gyn Obst. 1992;  174 501-506
• 45 Johnstone D W. Postoperative chylothorax.  Chest Surg Clin N Am. 2002;  12 597-603
• 46 De Beer H GJ, Mol M JT, Janssen J P. Chylothorax.  Neth J Med. 2000;  56 25-31
• 47 Doerr C H, Miller D L, Ryu J H. Chylothorax.  Semin Resp Crit Care Med. 2001;  22 617-626
• 48 Motoyama S, Okuyama M, Saito R et al. Magnetic resonance imaging for chylothorax after esophagectomy.  Jpn J Thorac Cardiovasc Surg. 2005;  53 434-436
• 49 Gomez-Caro A A, Moradiellos Diez F J, Marron C F et al. Conservative management of postsurgical chylothorax with octreotide.  Asian Cardiovasc Thoracic Ann. 2005;  13 222-224
• 50 Pratap U, Slavik Z, Ofoe V D et al. Octreotide to treat postoperative chylothorax after cardiac operations in children.  Ann Thorac Surg. 2001;  72 1740-1742
• 51 Selle G J, Snyder W H, Schreiber J T. Chylothorax: indications for surgery.  Ann Surg. 1973;  177 245-249
• 52 Alexiou C, Watson M, Beggs D et al. Chylothorax following oesophagogastrectomy for malignant disease.  Eur J Cardiothorac Surg. 1998;  14 460-466
• 53 Cerfolio R J, Allen M S, Deschamps C et al. Postoperative chylothorax.  J Thorac Cardiovasc Surg. 1996;  112 1361-1366
• 54 Dugue L, Sauvanet A, Farges O et al. Output of chyle as an indicator of treatment for chylothorax complicating esophagectomy.  Br J Surg. 1998;  85 1147-1149
• 55 Cope C, Salem R, Kaiser L R. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial.  J Vasc Interv Radiol. 1999;  10 1248-1254
• 56 Cope C, Kaiser L R. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients.  J Vasc Interv Radiol. 2002;  13 1139-1148
• 57 Binkert A B, Kent Yucel E, Davison B D et al. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique.  J Vasc Interv Radiol. 2005;  16 1257-1262
• 58 Hoffer E K, Bloch R D, Mulligan M S et al. Treatment of chylothorax: percutaneous catheterization and embolization of the thoracic duct.  Am J Roentgenol. 2001;  176 1040-1042
• 59 Schild H, Hirner A. Percutaneous translymphatic thoracic duct embolization for treatment of chylothorax.  Rofo. 2001;  173 580-582
• 60 Litherland B, Given M, Lyon S. Percutaneous radiological management of high-output chylothorax with CT-guided needle disruption.  J Med Imaging Radiat Oncol. 2008;  52 164-167
• 61 Fujiwara Y, Nakagawa K, Kusunoki M et al. Massive pleural effusion and ascites resulting from esophagectomy with extensive lymphadenectomy for cancer of the abdominal esophagus.  Hepato-Gastroenterology. 1999;  46 290-294
• 62 Nadesan S, Ming T C, Thangaveloo G et al. Treatment of delayed chylothorax complicating oesophagectomy.  Asian J Surg. 2005;  28 142-144
• 63 Ulibarri J I, Sanz Y, Fuentes C et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin.  Lancet. 1990;  336 258
• 64 Kelly R F, Shumway S J. Conservative management of postoperative chylothorax using somatostatin.  Ann Thorac Surg. 2000;  69 1944-1945
• 65 Mafe J J, Caravajal J M, Baschwitz B et al. Bilateral chylothorax after thymectomy via median sternotomy and resolution through conservative treatment.  Eur J Cardiothorac Surg. 2003;  24 466-468
• 66 Kalomenidis I. Octreotide and chylothorax.  Curr Opin Pulm Med. 2006;  12 264-267
• 67 Lim K A, Kim S H, Huh J et al. Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease.  J Korean Med Sci. 2005;  20 947-951
• 68 Rosti L, De Battisti F, Butera G et al. Octreotide in the management of postoperative chylothorax.  Pediatr Cardiol. 2005;  26 440-443
• 69 Tachibana M, Kinugasa S, Yoshimura H et al. Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.  World J Surg. 2003;  27 776-781

1 *Modified version of the manuscript recently published under Benedix et al. Post-surgical lymphocutaneous fistula, chylous ascites and chylothorax – infrequent but serious complications: etiology, diagnosis and therapeutic option.
Zentralbl Chir 2007; 132: 529–538 (DOI 10.1055/s-2007–981364 // ISSN 723–7065). Article in German.